↓ Skip to main content

The affordable medicines facility-malaria—A success in peril

Overview of attention for article published in Malaria Journal, November 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

blogs
1 blog
policy
2 policy sources
twitter
6 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
67 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The affordable medicines facility-malaria—A success in peril
Published in
Malaria Journal, November 2012
DOI 10.1186/1475-2875-11-370
Pubmed ID
Authors

Ambrose O Talisuna, Seraphine Adibaku, Chioma N Amojah, George K Amofah, Vivian Aubyn, Alex Dodoo, Elizabeth Juma, Djermakoye H Jackou, Sigsbert Mkude, Albert P Okui, Benjamin Ramarosandratana, Shija J Shija

Abstract

The Affordable Medicines Facility-malaria (AMFm) has put into place a bold financing plan for artemisinin-combination therapy in a pilot phase in seven countries covering half the population at risk of malaria in Africa. A report of the AMFm independent evaluation, conducted by ICF International and the London School of Hygiene and Tropical Medicine, describes the success of the programme in the pilot sites: Ghana, Kenya, Madagascar, Niger, Nigeria, Tanzania (mainland and Zanzibar) and Uganda, comparing availability and affordability of high-quality artemisinin-combination therapies before and after AMFm launched. Proof of concept was achieved: AMFm increased availability and kept prices low, meeting its initial, ambitious benchmarks in most settings. Despite this overwhelming success, opposition to the programme and dwindling resources for malaria control conspire to cripple or kill AMFm.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Burkina Faso 1 1%
Norway 1 1%
Unknown 64 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 15 22%
Researcher 14 21%
Student > Ph. D. Student 7 10%
Student > Bachelor 5 7%
Other 5 7%
Other 11 16%
Unknown 10 15%
Readers by discipline Count As %
Medicine and Dentistry 16 24%
Agricultural and Biological Sciences 8 12%
Pharmacology, Toxicology and Pharmaceutical Science 8 12%
Social Sciences 7 10%
Nursing and Health Professions 4 6%
Other 12 18%
Unknown 12 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 December 2020.
All research outputs
#2,016,167
of 24,400,706 outputs
Outputs from Malaria Journal
#389
of 5,827 outputs
Outputs of similar age
#13,530
of 187,186 outputs
Outputs of similar age from Malaria Journal
#4
of 86 outputs
Altmetric has tracked 24,400,706 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,827 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 187,186 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 86 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.